Filing Details

Accession Number:
0001209191-13-028237
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-22 20:54:05
Reporting Period:
2013-05-21
Filing Date:
2013-05-22
Accepted Time:
2013-05-22 19:54:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131324 Genomic Health Inc GHDX Services-Medical Laboratories (8071) 770552594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1337334 Steven Shak 301 Penobscot Drive
Redwood City CA 94063
Evp Of R&D & Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-21 5,000 $37.19 327,380 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 5, 2013.
  2. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  3. Represents weighted average sale price. Actual sale prices ranged from $36.95 to $37.35.
  4. Includes 4,500 restricted stock units awarded January 27, 2011, of which 1/3 of the shares vest on February 15, 2014, and the 1/3 of the shares that vested on each of February 15, 2012 and 2013, net of withholding.
  5. Includes 5,700 restricted stock units awarded February 5, 2012 which vest as to 1/3 of the shares on February 15, 2014 and 2015, and the 1/3 of the shares that vested on February 15, 2013, net of withholding.